Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering Nov 21, 2019 7:00am EST
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants Nov 18, 2019 7:00am EST
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences Sep 23, 2019 4:30pm EDT
Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38 Jun 17, 2019 8:00am EDT
Molecular Templates to Present at the Oppenheimer New York Oncology Insight Summit and the UBS Global Healthcare Conference May 14, 2019 4:30pm EDT
